Skip to main content
. 2015 May 14;38(6):371–377. doi: 10.1002/clc.22404

Figure 1.

CLC-22404-FIG-0001-c

In the ROC curve analysis, TGF‐β levels >4877 pg/mL had a sensitivity of 71% and specificity of 75% in predicting adverse events in HCM patients (area under curve: 0.727, 95% CI: 0.567–0.887, P = 0.014). Abbreviations: CI, confidence interval; HCM, hypertrophic cardiomyopathy; ROC, receiver operating characteristic; TGF‐β, transforming growth factor‐β.